WHAT ARE THE ALLEGATIONS IN THE SCYNEXIS CLASS ACTION LAWSUIT? The SCYNEXIS class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) the equipment used to manufacture ibrexafungerp was also used to manufacture a non-antibacterial beta-lactam drug substance, presenting a risk of cross-contamination; (ii) SCYNEXIS did not have effective internal controls and procedures, as well as adequate internal oversight policies to ensure that its vendor complied with current Good Manufacturing Practices; and (iii) due to the substantial risk of cross-contamination, SCYNEXIS was reasonably likely to recall its ibrexafungerp tablets and halt its clinical studies. The SCYNEXIS class action lawsuit further alleges that on September 25, 2023, SCYNEXIS revealed that following a recent review by GSK plc of the manufacturing process and equipment at the vendor that manufactures the ibrexafungerp drug substance, SCYNEXIS became aware of potential cross contamination of ibrexafungerp with a non-antibacterial beta-lactam drug substance. SCYNEXIS declared it would conduct a recall of BREXAFEMME from the market and place a temporary hold on clinical studies of ibrexafungerp, including a Phase 3 clinical study, until a mitigation strategy and a resupply plan are determined, according to the complaint. The SCYNEXIS class action lawsuit alleges that on this news, the price of SCYNEXIS stock fell more than 41% over two trading sessions. If you suffered losses in SCYNEXIS Cell stock, contact SCYNEXIS stock loss lawyer Timothy L. Miles today for a free case evaluation about a SCYNEXIS class action lawsuit. Call today and see what a SCYNEXIS stock loss lawyer could do for you if you suffered losses in SCYNEXIS Cell stock. The Law Offices of Timothy L. Miles Tapestry at Brentwood Town Center 300 Centerview Dr., #247 Brentwood, TN 37027 Phone: (855) 846-6529 Email: tmiles@timmileslaw.com
from
https://www.youtube.com/watch?v=4vAtOXWMH5w
Subscribe to:
Post Comments (Atom)
AUTODESK CLASS ACTION LAWSUIT
The Autodesk class action lawsuit seeks to represent purchasers or acquirers of Autodesk, Inc. (NASDAQ: ADSK) publicly traded securities bet...
-
JUUL ADDICTION LAWSUIT from https://www.youtube.com/watch?v=hDwYmVVvxJE
-
Top Workers Compensation Attorney Nashville from https://www.youtube.com/watch?v=rbSDfQqLZdo
-
NASHVILLE OZEMPIC LAWYER LAW OFFICES OF TIMOTHY L. MILES (855) 846-6529 | tmiles@timmileslaw.com WHAT ABOUT OZEMPIC AND PANCREATITIS? FROM A...
No comments:
Post a Comment